IGC Pharma
IGC
#10740
Rank
HK$0.16 B
Marketcap
HK$1.60
Share price
2.20%
Change (1 day)
-45.75%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

IGC Pharma (IGC) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : HK$24.03 Million

According to IGC Pharma's latest financial reports the company's total liabilities are HK$24.03 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

IGC Pharma - Total liabilities on balance sheet (from 2006 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31HK$17.79 M-22.78%
2022-03-31HK$23.04 M-3.25%
2021-03-31HK$23.82 M25.58%
2020-03-31HK$18.96 M170.61%
2019-03-31HK$7 M-67.97%
2018-03-31HK$21.88 M-28.42%
2017-03-31HK$30.57 M-19.74%
2016-03-31HK$38.09 M-11.98%
2015-03-31HK$43.27 M55.45%
2014-03-31HK$27.83 M-16.18%
2013-03-31HK$33.21 M-54.71%
2012-03-31HK$73.32 M-13.27%
2011-03-31HK$84.53 M18.12%
2010-03-31HK$71.57 M-33.91%
2009-03-31HK$0.10 B-47.98%
2008-03-31HK$0.20 B50.01%
2007-03-31HK$0.13 B13.03%
2006-03-31HK$0.12 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sterling Infrastructure
STRL
HK$15.11 B 62,792.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
HK$56.57 B 235,317.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
HK$31.16 B 129,584.73%๐Ÿ‡บ๐Ÿ‡ธ USA